First-generation oral antivirals against SARS-CoV-2
Review article
Published on
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 치료제,
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 치료제,
[키워드] acute respiratory syndrome
Antiviral
antiviral agent
Clinical practice
clinical trials
Compliance
content
coronavirus
COVID-19
death
drug
drug-drug interaction
early administration
Efficacy
Emergency use authorization
Frequency
Google Scholar
high risk
Hospitalization
Hospitalized
Immunosuppressed
include
individual
ingestion
Mild-to-moderate
molnupiravir
Nirmatrelvir
objective
oral
Patient
persistence
progression
reduced
reference
Regulatory
required
risk reduction
Ritonavir
SARS-CoV-2
Source
Toxicity
Treatment
website
[DOI] 10.1016/j.cmi.2022.04.015 [Article Type] Review article
[DOI] 10.1016/j.cmi.2022.04.015 [Article Type] Review article